Starling Oncology, Inc.

$25m committed across 1 active facility, next covenant test Sep 30, 2026. STLN · DFPH · STLNW

Services-Offices & Clinics of Doctors of Medicine

Recent changes

  1. Aug 21, 2026Starling Oncology, Inc. signs $25m CREDIT AGREEMENT, matures Aug 2029SEC ↗
Tested quarterlyHeadroom not yet measured35.00
Borrower’s Maximum Loan Turn Days shall be no more than thirty-five (35) days, tested quarterly on a rolling three-month basis on the last Business Day of each fiscal quarter commencing with the fiscal quarter ending December 31, 2026 and continuing each fiscal quarter thereafter.
Read the filing on sec.gov ↗

Download CSV · Download JSON

CREDIT AGREEMENT

Signed Aug 20, 2026

Committed
$25m
Matures
Aug 2029
Agent
Not stated
TrancheSizeMaturesMargin
Revolving Loans$25mAug 2029n/a

Priced over Term SOFR, floor 200 bps (Revolving credit facility).

LevelConditionMarginUnused fee
Level Level 1all timesn/an/a

§2.03

Lenders: GEMINO HEALTHCARE FINANCE, LLC d/b/a SLR HEALTHCARE ABL

No amendments on file yet.

Report an error

Email [email protected].